According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Veterinary Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Veterinary Vaccine market.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system's production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Key Features:
The report on Veterinary Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Veterinary Vaccine market. It may include historical data, market Segmentation by Type (e.g., Live Attenuated Vaccines, Inactivated Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Veterinary Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Veterinary Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Veterinary Vaccine industry. This include advancements in Veterinary Vaccine technology, Veterinary Vaccine new entrants, Veterinary Vaccine new investment, and other innovations that are shaping the future of Veterinary Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Veterinary Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Veterinary Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Veterinary Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Veterinary Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Veterinary Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Veterinary Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Veterinary Vaccine market.
Market Segmentation:
Veterinary Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Live Attenuated Vaccines
- Inactivated Vaccines
- Other
Segmentation by application
- Farm Animal
- Companion Animal
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- RVSRI
- Medion
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out type, application?
Global Veterinary Vaccine Market Growth 2024-2030
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2019-2024)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2019-2024)
3 Global Veterinary Vaccine by Company
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Veterinary Vaccine Revenue by Company (2019-2024)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Vaccine by Geographic Region
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 Americas
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2019-2024)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2019-2024)
5.2 Americas Veterinary Vaccine Sales by Type
5.3 Americas Veterinary Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2019-2024)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2019-2024)
6.2 APAC Veterinary Vaccine Sales by Type
6.3 APAC Veterinary Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2019-2024)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2019-2024)
7.2 Europe Veterinary Vaccine Sales by Type
7.3 Europe Veterinary Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type
8.3 Middle East & Africa Veterinary Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 World Forecast Review for Veterinary Vaccine by Geographic Region
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2025-2030)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Vaccine Forecast by Type
12.7 Global Veterinary Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
13.26 Medion
13.26.1 Medion Company Information
13.26.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.26.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Medion Main Business Overview
13.26.5 Medion Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Veterinary Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Veterinary Vaccine Sale Price by Type (2019-2024) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 12. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Veterinary Vaccine Revenue by Application (2019-2024)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Veterinary Vaccine Sale Price by Application (2019-2024) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2019-2024) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Veterinary Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Veterinary Vaccine Sale Price by Company (2019-2024) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2019-2024) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2019-2024) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Americas Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. APAC Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Veterinary Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 45. APAC Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 46. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 57. Middle East & Africa Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 59. Key Market Challenges & Risks of Veterinary Vaccine
Table 60. Key Industry Trends of Veterinary Vaccine
Table 61. Veterinary Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Vaccine Distributors List
Table 64. Veterinary Vaccine Customer List
Table 65. Global Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 66. Global Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 68. Americas Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 70. APAC Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 72. Europe Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Veterinary Vaccine Sales Forecast by Type (2025-2030) & (M Doses)
Table 76. Global Veterinary Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Veterinary Vaccine Sales Forecast by Application (2025-2030) & (M Doses)
Table 78. Global Veterinary Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 81. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 86. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Zoetis Main Business
Table 88. Zoetis Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 96. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 101. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 106. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 116. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 121. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 126. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 131. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Elanco Main Business
Table 133. Elanco Latest Developments
Table 134. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 136. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 151. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 157. Kyoto Biken Laboratories Main Business
Table 158. Kyoto Biken Laboratories Latest Developments
Table 159. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 161. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 177. Avimex Animal Health Main Business
Table 178. Avimex Animal Health Latest Developments
Table 179. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 181. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 182. MEVAC Main Business
Table 183. MEVAC Latest Developments
Table 184. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 186. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 187. Biovac Main Business
Table 188. Biovac Latest Developments
Table 189. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 191. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 192. Atafen Main Business
Table 193. Atafen Latest Developments
Table 194. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 196. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 197. Dyntec Main Business
Table 198. Dyntec Latest Developments
Table 199. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 201. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 202. RVSRI Main Business
Table 203. RVSRI Latest Developments
Table 204. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 205. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 206. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 207. Medion Main Business
Table 208. Medion Latest Developments
List of Figures
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth R
Global Classical Swine Fever Vaccines Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 100
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
Global Tylosin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
Global Animal Parasiticides Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
Global Newcastle Disease Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
Global Classical Swine Fever Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 126
According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
Global Veterinary Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
Global Veterinary Products for Companion Animals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 115
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
